×
About 4,330 results

ALLMedicine™ Gastrointestinal Cancers Center

Research & Reviews  1,709 results

A 10-year cohort study of 175 primary gastrointestinal lymphoma cases in Thailand: clin...
https://doi.org/10.1080/16078454.2021.1889160
Hematology (Amsterdam, Netherlands); Owattanapanich W, Ruchutrakool T et. al.

Feb 23rd, 2021 - Primary gastrointestinal lymphoma (PGIL), an uncommon subtype of lymphoma, accounts for 1%-4% of gastrointestinal cancers. This study, therefore, aimed to investigate the current 10-year epidemiology and outcomes of PGIL. This retrospective study ...

Impact of mental illness on end-of-life emergency department use in elderly patients wi...
https://doi.org/10.1002/cam4.3792
Cancer Medicine; Kashyap M, Harris JP et. al.

Feb 23rd, 2021 - Elderly patients with gastrointestinal cancer and mental illness have significant comorbidities that can impact the quality of their care. We investigated the relationship between mental illness and frequent emergency department (ED) use in the la...

Endoscopic Submucosal Dissection (ESD) in North America: A Large Prospective Multicente...
https://doi.org/10.1053/j.gastro.2021.02.036
Gastroenterology Draganov PV, Aihara H et. al.

Feb 21st, 2021 - Endoscopic submucosal dissection (ESD) in Asia has been shown to be superior to endoscopic mucosal resection (EMR) and surgery for the management of selected early gastrointestinal cancers. We aimed to evaluate technical outcomes of ESD in North A...

Screening for upper gastrointestinal cancers with magnetically controlled capsule gastr...
https://doi.org/10.1055/a-1333-2120
Endoscopy Li Z, Liu J et. al.

Feb 13th, 2021 - The medical consortium is an intensive and disease-specific association that integrates tertiary public hospitals and medical examination centers in China. We aimed to evaluate the feasibility of the medical consortium for screening upper gastroin...

see more →

Guidelines  9 results

Expert Perspective on ASCO20 Gastrointestinal Cancers Research
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200231/full/

Jul 1st, 2020 - Donafenib, a deuterated derivative of sorafenib, was tested against sorafenib in the frontline setting in hepatitis B– associated hepatocellular carcinoma (HCC) in a large, multi-institutional study in China (Abstract 4506).

Hereditary Gastrointestinal Cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
https://academic.oup.com/annonc/advance-article-pdf/doi/10.1093/annonc/mdz233/29094053/mdz233.pdf

Aug 4th, 2019 - Knowledge of genetic susceptibility to gastrointestinal cancers is constantly evolving with identification of new genes. Similarly, a better understanding of the genotype/phenotype relationship in patients with Lynch syndrome (LS) or familial aden...

A phase II/III trial presented by Unno et al at the 2019 Gastrointestinal Cancers Symposium (Abstract 189) sought to compare neoadjuvant chemotherapy (using gemcitabine and the oral fluoropyrimidin...
http://ascopost.com/News/59662
ASCO Post

Jan 17th, 2019 - A phase II/III trial presented by Unno et al at the 2019 Gastrointestinal Cancers Symposium (Abstract 189) sought to compare neoadjuvant chemotherapy (using gemcitabine and the oral fluoropyrimidine combination of tegafur/gimeracil/oteracil [S-1])...

ASCO Gastrointestinal Cancers Symposium
https://gicasym.org/
ASCO

Jan 16th, 2019 - The Gastrointestinal (GI) Cancers Symposium is a three-day specialized meeting designed to provide scientific and educational content for members of the GI cancer care and research community. This meeting encompasses the latest science in cancers ...

Proteus Digital Health® Launches Digital Oncology Medicines to Improve Patient Outcomes
https://www.proteus.com/press-releases/proteus-digital-health-launches-digital-oncology-medicines-to-improve-patient-outcomes/

Jan 16th, 2019 - Proteus Digital Health®, Inc., Fairview Health Services, and University of Minnesota Health announced today that for the first time cancer patients are using digital oncology medicines to support treatment regimens and improve outcomes. This adva...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  2,301 results

Updated Findings Bolster the Use of Checkpoint Inhibitors in Treatment of Liver Cancer
https://ascopost.com/issues/february-25-2021/updated-findings-bolster-the-use-of-checkpoint-inhibitors-in-treatment-of-liver-cancer/

Feb 24th, 2021 - Although optimal regimens are still being determined, checkpoint inhibition has clearly established itself in the treatment of hepatocellular carcinoma, as judged by the number of abstracts on the topic at the 2021 Gastrointestinal Cancers Symposi...

ASCO Names Advance of the Year: Molecular Profiling Drives Progress in Gastrointestinal Cancers
https://ascopost.com/issues/february-25-2021/asco-names-advance-of-the-year-molecular-profiling-drives-progress-in-gastrointestinal-cancers/

Feb 24th, 2021 - Molecular profiling allows clinicians to identify the molecular and genetic signatures that help to deliver treatments that are highly specific to a tumor. This tool has made possible a number of advances in the past year that are improving care f...

A 10-year cohort study of 175 primary gastrointestinal lymphoma cases in Thailand: clin...
https://doi.org/10.1080/16078454.2021.1889160
Hematology (Amsterdam, Netherlands); Owattanapanich W, Ruchutrakool T et. al.

Feb 23rd, 2021 - Primary gastrointestinal lymphoma (PGIL), an uncommon subtype of lymphoma, accounts for 1%-4% of gastrointestinal cancers. This study, therefore, aimed to investigate the current 10-year epidemiology and outcomes of PGIL. This retrospective study ...

Impact of mental illness on end-of-life emergency department use in elderly patients wi...
https://doi.org/10.1002/cam4.3792
Cancer Medicine; Kashyap M, Harris JP et. al.

Feb 23rd, 2021 - Elderly patients with gastrointestinal cancer and mental illness have significant comorbidities that can impact the quality of their care. We investigated the relationship between mental illness and frequent emergency department (ED) use in the la...

see more →

News  309 results

Highlights From ASCO GI: Data That Will 'Advance Care'
https://www.medscape.com/viewarticle/944777

Jan 31st, 2021 - This transcript has been edited for clarity. Hello. This is Dr Mark Lewis, coming to you the weekend after the 2021 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium. Once again, we were unable to meet in person due t...

Expert Perspective on ASCO20 Gastrointestinal Cancers Research
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200231/full/

Jul 1st, 2020 - Donafenib, a deuterated derivative of sorafenib, was tested against sorafenib in the frontline setting in hepatitis B– associated hepatocellular carcinoma (HCC) in a large, multi-institutional study in China (Abstract 4506).

Cancer Care 'Transformed in Space of a Month' Due to Pandemic
https://www.staging.medscape.com/viewarticle/928801

Apr 15th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. There will be some change for the better when oncology care emerges from the COVID-19 pandemic, the most "revolutionary" being a deep dive into te...

Cancer Care 'Transformed in Space of a Month' Due to Pandemic
https://www.medscape.com/viewarticle/928801

Apr 15th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. There will be some change for the better when oncology care emerges from the COVID-19 pandemic, the most "revolutionary" being a deep dive into te...

Colorectal Cancer: Proposed Treatment Guidelines for the COVID-19 Era
https://www.medscape.com/viewarticle/928133

Apr 2nd, 2020 - In light of the rapid changes affecting cancer clinics due to the COVID-19 pandemic, Drs David Kerr and Rachel Kerr, both specialists in gastrointestinal cancers at the University of Oxford in Oxford, United Kingdom, drafted these guidelines for t...

see more →

Patient Education  1 results see all →